- Report
- November 2023
- 250 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- July 2023
- 220 Pages
Global
€4636EUR$4,795USD£3,982GBP
- Report
- February 2024
- 104 Pages
Europe
From €2852EUR$2,950USD£2,450GBP
- Report
- November 2023
- 101 Pages
Asia Pacific
From €2369EUR$2,450USD£2,035GBP
- Report
- November 2022
- 418 Pages
Global
From €2350EUR$2,604USD£2,089GBP
- Report
- April 2022
- 131 Pages
Global
From €1256EUR$1,299USD£1,079GBP
- Report
- April 2023
- 206 Pages
Global
From €6768EUR$7,000USD£5,813GBP
- Report
- December 2019
- 64 Pages
Global
- Report
- April 2020
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- November 2021
- 527 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- November 2021
- 802 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- November 2021
- 1184 Pages
Global
From €5801EUR$6,000USD£4,983GBP
- Report
- February 2023
- 280 Pages
Global
From €5540EUR$5,730USD£4,758GBP
- Report
- December 2021
- 170 Pages
Global
From €5963EUR$6,168USD£5,122GBP
- Book
- March 2022
- 896 Pages
Ribozyme is a type of RNA molecule that can act as a catalyst in biochemical reactions. It is used in genomics to study gene expression, protein synthesis, and other cellular processes. Ribozymes are also used in gene therapy, as they can be used to target and cleave specific mRNA molecules. Ribozymes are also used in the development of new drugs, as they can be used to target and inhibit specific proteins.
Ribozyme technology has been used in a variety of research applications, including the study of gene regulation, protein-protein interactions, and the development of new therapeutic agents. The market for ribozymes is expected to grow in the coming years, as the technology is increasingly used in the development of new drugs and therapies.
Some companies in the ribozyme market include Twist Bioscience, Ribozyme Pharmaceuticals, and Ribozyme Technologies. Show Less Read more